Latest News about CCC
Recent news which mentions CCC
Ukraine Approves Medical Marijuana For Certain Health Conditions, PTSD Left Out For Now
September 30, 2024
From Benzinga
Medical Marijuana's Role In Cannabis Reform: Why It Can't Be Ignored
September 30, 2024
Tickers
CCC
From Benzinga
GOP Senator Leads Bipartisan Effort To Seal Low-Level Marijuana Possession Records, Providing 'Second Chance'
September 30, 2024
From Benzinga
'No Companies Will Invest': How California's Hemp Rules Could Hurt Cannabis Businesses
September 30, 2024
From Benzinga
'Get Ready For A Nationwide Game Of Whack-A-Mole': What California's Hemp Ban Means For The Industry
September 30, 2024
Tickers
CCC
From Benzinga
Cannabis Investors 'Actively Chasing' Companies Expanding Beyond The Industry Says Expert
September 27, 2024
Tickers
CCC
From Benzinga
Has Medical Marijuana Been Forgotten In Cannabis Reform? 'Its Therapeutic Benefits Are Critical'
September 27, 2024
Tickers
CCC
From Benzinga
'Medical Marijuana is Still Critical': Balancing Act Between Recreational, Medicinal Markets
September 26, 2024
Tickers
CCC
From Benzinga
California's Hemp Restrictions Could 'Stifle Broader Access' To Therapeutic Products, Expert Warns
September 26, 2024
Tickers
CCC
From Benzinga
Nasdaq-Listed Vaping Company Ispire Reports 31% YoY Increase In 2024 Revenue
September 26, 2024
From Benzinga
LeafLink's New Payment Option Is Vital For Cannabis Retailers Facing Financial Strain
September 26, 2024
From Benzinga
'Investors Are Looking Beyond The Hype': What's Driving Cannabis Investments Today?
September 25, 2024
Tickers
CCC
From Benzinga
Multi-Billion-Dollar Fund Manager Ross Gerber Will Discuss Cannabis And Its Financial Future At This Key Chicago Event
September 25, 2024
From Benzinga
Rescheduling Cannabis: What The First Pro-Legalization Presidential Ticket Could Mean For The Industry
September 25, 2024
Tickers
CCC
From Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
From Benzinga
Woman Busted For Growing 600 Weed Plants In Maine Did It For The Smell, They're 'Like My Babies'
September 24, 2024
From Benzinga
Illicit Cannabis Market Balloons To $79 Billion: Is Rescheduling Enough To Fix The System?
September 24, 2024
Tickers
CCC
From Benzinga
EXCLUSIVE: How Green Check is Helping Indigenous Cannabis Businesses Get The Banking They Need
September 24, 2024
From Benzinga
Cannabis Sales Bloom In First North Carolina Weed Store, Marijuana Footprint In Florida Grows As Rec Legalization Looms, And More Store Openings
September 23, 2024
From Benzinga
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?
September 23, 2024
From Benzinga
Buying Cannabis At Pharmacy Feels 'More Comfortable,' Says Owner Of Georgia Drugstore Launching Low-THC MMJ Sales
September 20, 2024
From Benzinga
Canadian Cannabis Retail Giant Tokyo Smoke Restructures, Seeks Stronger Future Via $56.7M Share Deal
September 20, 2024
From Benzinga
Aurora Cannabis CEO Takes On Dual Role: Here's What's Behind The Leadership Change
September 20, 2024
From Benzinga
Hemp-Derived Products Like Delta-8 THC Are 'Here To Stay,' Says Analyst
September 20, 2024
Tickers
CCC
From Benzinga
Candidates For West Virginia Governor Are Split Over Weed Legalization: Here's What Voters Should Know
September 19, 2024
From Benzinga
Flora Growth Cannabis Expands European Presence With Strategic Supply Agreement For Medical Marijuana
September 19, 2024
From Benzinga
'No Turning Back Now': Cannabis Rescheduling Gains Momentum, Expert Offers Timeline
September 19, 2024
Tickers
CCC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.